7.210SEK+0.56%Mkt Cap: 192.01M SEKP/E: —Last update: 2026-05-13
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses syste…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B1.05
P/S1.96
EV/EBITDA-4.04
EV/Revenue1.69
EPS (TTM)-1.66
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-11.28%
FCF Margin-22.06%
Operating CF-38.32M SEK
CapEx (TTM)11.89M SEK
Net Debt/EBITDA0.65
Net Debt-26.57M SEK
Technical
SMA 507.618 (-5.4%)
SMA 20014.15 (-49.0%)
Beta0.36
S&P 52W Chg24.23%
Avg Vol (30d)39.74K
Avg Vol (10d)40.61K
Technical Indicators
RSI (14)39.8
MACD-0.1418
MACD Signal-0.0516
MACD Hist.-0.0902
BB Upper8.869 SEK
BB Middle7.899 SEK
BB Lower6.928 SEK
BB Width24.58%
ATR (14)0.4038 SEK
Vol Ratio (20d)0.54x
52W Range
6.4002% of range43.15
52W High43.15 SEK
52W Low6.400 SEK
Profitability
Gross Margin82.75%
EBITDA Margin-41.73%
Profit Margin-33.83%
Oper. Margin-43.80%
ROE-17.35%
ROA-15.18%
Revenue Growth-17.10%
Earnings Growth—
Balance Sheet
Debt/Equity0.03
Current Ratio4.40
Quick Ratio2.70
Book Value/Sh6.844 SEK
Cash/Share1.131 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.26.03M
Float17.85M
Insiders45.46%
Institutions16.33%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap192.01M SEK
Enterprise Value165.43M SEK
Revenue (TTM)98.18M SEK
Gross Profit75.38M SEK
Net Income (TTM)-30.82M SEK
Revenue/Share4.355 SEK
Fiscal Year EndApr 2025
MR QuarterJan 2026
Employees35
Last Price7.210 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—